Theralase(R) Closes $1.1 M Non-Brokered Private PlacementTSXV:TLTOTCQB:TLTFF|Neutral|10 Mar 2026 · 4 days agoRead More →
Theralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder CancerTSXV:TLTOTCQB:TLTFF|Bullish|9 Mar 2026 · 5 days agoRead More →
Light-Activated Ruvidar and Interferon Demonstrate Enhanced EfficacyTSXV:TLTOTC:TLTFF|Bullish|2 Mar 2026 · 12 days agoRead More →